ProCE Banner Activity

CE / CME

What Do I Need to Know About Recent Advances in the Treatment of Schizophrenia?

Virtual Lecture

Schizophrenia is a complex illness where a multidisciplinary approach can help to address unmet needs. In this webinar, an expert discusses evidence-based treatments for schizophrenia, nonpharmacologic therapies, the importance of early intervention and coordinated specialty care, and new innovative treatments.

Registered Nurses: 1.00 Nursing contact hours, includes 1.00 hour of pharmacology credit Physician Assistants: maximum of 1.00 hours of AAPA Category 1 CME credits

Released: January 24, 2022

Expiration: January 23, 2023

Begin Activity

Share

Faculty

Michael Asbach

Michael Asbach, DMSc, PA-C, Psych-CAQ

Adjunct Professor
Department of Physician Assistant Studies
Daemen College
Associate Director Interventional Psychiatry
Department of Neuropsychiatry and Interventional Psychiatry
DENT Neurologic Institute
Amherst, New York

Patricia Cunningham

Patricia Cunningham, DNSc, PMHNP, FNP

Sub-Investigator (PRN)
Clinical Neuroscience Solutions
Memphis, Tennessee

Acknowledgement

This program was cosupported by educational grants from AbbVie Inc.; Intra-Cellular Therapies; Neurocrine; and Sunovion.

This activity is supported by educational grants from Intra-Cellular Therapies and Sunovion.

Provided by

ProCE Banner

Target Audience

NPs and PAs

Learning Objectives

Upon completion of this activity, participants should be able to:
  • Discuss the unmet needs in the treatment of schizophrenia

  • Educate on evidence-based treatments for schizophrenia

  • Describe the role of nonpharmacologic therapies in schizophrenia

  • Discuss new innovative treatments for the illness

  • Individualize treatment choices, giving consideration to efficacy, safety, and long-term data

Disclosure

All faculty and planners participating in continuing education activities sponsored by Practicing Clinicians Exchange (PCE) are required to disclose to the audience all financial relationships with ineligible companies. All relevant conflicts of interest are thoroughly vetted and mitigated according to PCE policy. In addition, all faculty are required to openly disclose any off-label, experimental, or investigational use of drugs or devices discussed in this activity. The faculty and Planning Committee have been advised that this activity must be free from commercial bias and based upon all available scientifically rigorous data from research that conforms to accepted standards of experimental design, data collection, and analysis.

Dr Asbach has disclosed that he has received consulting fees from Biogen and Neurocrine Biosciences; and has received fees for non-CME/CE services from AbbVie, Avanir, Johnson & Johnson, Otsuka, and Neurocrine Biosciences.

Dr Cunningham has no relevant financial relationships to disclose.

None of the members of the Planning Committee or PCE staff have any relevant relationships to disclose.

CME Info

Participants wishing to earn CE/CME credit must:

  1. View the content in its entirety
  2. Relate the content material to the learning objectives
  3. Complete the post-test and evaluation form

Successful completion of the post-test is required to earn CE/CME credit. Successful completion is defined as a cumulative score of at least 75%.

The estimated time to complete this activity is 1.00 hour.

Release date: January 24, 2022
Expiration date: January 23, 2023

Format

Interactive video lecture

Disclaimer

The opinions or views expressed in this CE/CME activity do not necessarily reflect the opinions or recommendations of Practicing Clinicians Exchange or any educational supporter.

Accreditation

PCE

Joint Accreditation Statement

Joint AccreditationIn support of improving patient care, Practicing Clinicians Exchange is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

ANCC Credit Designation

NP course advisor: Patricia Cunningham, DNSc, PMHNP, FNP, Clinical Neuroscience Solutions, Memphis, Tennessee

Nursing contact hours: 1.00, which includes 1.00 hour of pharmacology credit

AAPA Credit Designation

Joint AccreditationPracticing Clinicians Exchange has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credit. Approval is valid until January 23, 2023. PAs should only claim credit commensurate with the extent of their participation.

IPCE Credit Designation
IPCEThis activity was planned by and for the healthcare team, and learners will receive 1.00 Interprofessional Continuing Education (IPCE) credit for learning and change.

Additional Information

Program Medium

This program has been made available online.